Patents by Inventor Teresa Brodniewicz

Teresa Brodniewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5856308
    Abstract: The invention provides artificial collagen comprising a stabilized ordered triple helix of copolypeptide strands containing repeating amino acid triads. The collagen may be modified with groups which improve its physical or chemical properties for the intended use, such as adhesive and cross-linking groups. Artificial collagen according to the invention is particularly useful as a wound closer and healer.
    Type: Grant
    Filed: September 27, 1996
    Date of Patent: January 5, 1999
    Assignee: Haemacure Corporation
    Inventors: Serge St. Pierre, Teresa Brodniewicz
  • Patent number: 5630842
    Abstract: The invention provides a biocompatible surgical implant particularly useful for breast or testicular reconstruction or augmentation comprising a stabilized fibrin semisolid, optionally sealed in a shaped shell. Preferred starting material for production of the implant is whole plasma from autologous or homologous donation, concentrated with respect to fibrinogen.
    Type: Grant
    Filed: January 26, 1994
    Date of Patent: May 20, 1997
    Assignee: Haemacure Biotech Inc.
    Inventor: Teresa Brodniewicz
  • Patent number: 5506127
    Abstract: A process for the large-scale production of therapeutic grade thrombin of excellent viral safety and storage-stability is carried out by purification of viricide treated crude thrombin by ion-exchange chromatography on a single column using a sulfalkyl-activated polysaccharide, particularly a non-compressible composite medium of sulfoalkyl-activated dextran and silica particles, as the ion exchange medium and using increasing concentrations of phosphate buffer for elution. After recovery of thrombin in the final eluate, the phosphate buffer is exchanged for a stabilizing formulation buffer, and the stabilized thrombin is subjected to viral filtration and optional dry heat treatment for further viral inactivation. The final product has high specific activity and is obtained in good yield.
    Type: Grant
    Filed: September 21, 1994
    Date of Patent: April 9, 1996
    Inventors: Zbigniew Proba, Teresa Brodniewicz